Distinguishing the progression of an endometrioma: Benign or malignant?

BAŞTU, Ercan; Onder, Semen; Demiral, Irem; Ozsurmeli, Mehmet; Keskin, Gulsah; TAKMAZ, Özgüç; Ozaltin, Selin; GÖRGEN, Hüsnü; GÜNGÖR, Mete; Yavuz, Ekrem; Buyru, Ercan

doi:10.1016/j.ejogrb.2018.09.026

Distinguishing the progression of an endometrioma: Benign or malignant?

Copy For Citation

BAŞTU E., Onder S., Demiral I., Ozsurmeli M., Keskin G., TAKMAZ Ö., ...More

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol.230, pp.79-84, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 230
Publication Date: 2018
Doi Number: 10.1016/j.ejogrb.2018.09.026
Journal Name: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.79-84
Istanbul University Affiliated: Yes

Abstract

Objective: To elucidate the immunohistochemical (IHC) differences of endometrioma tissues that may have the potential to progress to ovarian clear cell carcinoma (OCCC) by using KRAS, HNF1 beta, PIK3CA, PPP2R1A, and ARID1A as biomarkers.